MYND Life Sciences Inc. (CSE: MYND)

Canada flag Canada · Delayed Price · Currency is CAD
0.100
+0.020 (25.00%)
Jan 20, 2025, 11:14 AM EST
185.71%
Market Cap 4.78M
Revenue (ttm) 1.00
Net Income (ttm) -542.57K
Shares Out 47.82M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16,500
Average Volume 2,924
Open 0.100
Previous Close 0.080
Day's Range 0.100 - 0.100
52-Week Range 0.010 - 0.140
Beta 1.32
RSI 55.80
Earnings Date Feb 28, 2025

About MYND Life Sciences

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO John Campbell
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MYND
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.